Trevena Inc. buy melinda
Start price
21.11.17
/
50%
€42.17
Target price
19.12.17
€58.63
Performance (%)
-14.71%
End price
19.12.17
€35.97
Summary
This prediction ended on 19.12.17 with a price of €35.97. The prediction for Trevena Inc. disappointed with a performance of -14.71%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trevena Inc. | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by melinda for this prediction
In the thread Trevena Inc. diskutieren
Trevena, Inc. ist ein biopharmazeutisches company.It entdeckt, entwickelt
(Vom Mitglied beendet)


